health-issue
Media Update: Sanofi update on Zantac litigation
https://ift.tt/cwIu3S4 Sanofi update on Zantac litigation from Sanofi - Aventis Groupe https://ift.tt/GUVLPMr via IFTTT
Read more
health-issue
Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan
https://ift.tt/plbZu6V Sanofi launches 2024 global Employee Stock Purchase Plan from Sanofi - Aventis Groupe https://ift.tt/oOHRctD via IFTTT
Read more
health-issue
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with type 2 inflammation
https://ift.tt/z3UdqOj from Sanofi - Aventis Groupe https://ift.tt/CXtZpzg via IFTTT
Read more
health-issue
Press Release: Sanofi completes acquisition of Inhibrx, Inc.
https://ift.tt/ByYXWro Sanofi completes acquisition of Inhibrx, Inc. from Sanofi - Aventis Groupe https://ift.tt/HgKkCef via IFTTT
Read more
health-issue
Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myeloma
https://ift.tt/TOZCYia from Sanofi - Aventis Groupe https://ift.tt/FeV2OIA via IFTTT
Read more
health-issue
Media Update: New results from rilzabrutinib phase 2 study show potential to be first advanced oral treatment for moderate-to-severe asthma
https://ift.tt/BvtVAcM New results from rilzabrutinib phase 2 study show potential to be first advanced oral treatment for moderate-to-severe asthma …
Read more
health-issue
Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
https://ift.tt/BV6btO0 Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration from Sanofi - Aventis Groupe https://ift.tt/UqAQn…
Read more
health-issue
Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM
https://ift.tt/ePwYfTG from Sanofi - Aventis Groupe https://ift.tt/nrzsOaQ via IFTTT
Read more
health-issue
Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty
https://ift.tt/R6E9xkI from Sanofi - Aventis Groupe https://ift.tt/LZWGMmV via IFTTT
Read more
health-issue
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines
https://ift.tt/LjfJ1c4 Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-CO…
Read more
health-issue
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations
https://ift.tt/CiS5r43 Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations from Sanofi - Aven…
Read more